Biogen Pharmachem's board approved a 1:6 bonus issue of 15,04,33,833 equity shares funded from securities premium.
Authorized share capital to increase from Rs. 91 crore to Rs. 108 crore, subject to shareholder approval via postal ballot.
M/s. Goenka Mehta & Associates appointed as new statutory auditor replacing M/s. Rishi Sekhri & Associates, who resigned due to medical conditions.
Post-bonus paid-up equity share capital will rise from Rs. 90,26,03,000 to Rs. 1,05,30,36,833, with allotment within two months of board approval.